In the realm of breast cancer diagnosis and treatment, precision and accuracy in identifying the nature of the tumor are paramount. Among the various tests employed to achieve this, the Immunohistochemistry HER-2/neu (ErbB2) Breast Test stands out as a critical tool. This test is specifically designed to detect the overexpression of the HER-2 protein in breast cancer cells, a factor that influences treatment decisions and prognostic evaluations. DNA Labs UAE, a leading facility in genetic testing, offers this vital test, ensuring that patients and healthcare providers have access to crucial information for managing breast cancer effectively.
Symptoms Indicating the Need for an Immunohistochemistry HER-2/neu (ErbB2) Breast Test
While the Immunohistochemistry HER-2/neu (ErbB2) Breast Test itself is not a screening tool for breast cancer, certain symptoms and clinical findings might prompt a healthcare provider to recommend this test. These symptoms are generally associated with breast cancer and include:
- A lump or thickening in or near the breast or underarm area
- Changes to the skin over the breast, such as dimpling or puckering
- Changes in the size or shape of the breast
- Nipple discharge, especially if it’s bloody or clear
- Scaliness, redness, or thickening of the nipple or breast skin
- A nipple that is turned inward
It’s important to note that these symptoms can be caused by conditions other than cancer. However, if you experience any of these symptoms, it’s crucial to consult a healthcare provider for a thorough evaluation, which may include the Immunohistochemistry HER-2/neu (ErbB2) Breast Test if breast cancer is suspected.
Understanding the HER-2/neu Protein and Its Role in Breast Cancer
The HER-2/neu protein is a part of the human epidermal growth factor receptor (HER) family, which plays a significant role in the growth, division, and repair of cells. When the HER-2/neu gene is amplified or overexpressed in breast cancer cells, it can lead to aggressive tumor growth and spread. Identifying the presence of HER-2 overexpression is crucial as it directly influences treatment options and decisions. Targeted therapies, such as trastuzumab (Herceptin) and pertuzumab (Perjeta), are specifically designed to combat HER-2-positive breast cancers, highlighting the importance of accurate HER-2 status determination.
The Immunohistochemistry HER-2/neu (ErbB2) Breast Test Procedure
The test involves analyzing a tissue sample from the breast tumor, which is typically obtained through a biopsy. The sample is then processed and stained with specific antibodies that bind to the HER-2 protein, if present. The intensity of the staining and the percentage of cells stained are evaluated to determine the HER-2 status of the tumor. The results are usually reported on a scale from 0 to 3+, with 0 and 1+ considered negative, 2+ borderline, and 3+ positive for HER-2 protein overexpression.
Cost and Accessibility of the Test at DNA Labs UAE
Understanding the financial aspects of healthcare is crucial for patients. DNA Labs UAE offers the Immunohistochemistry HER-2/neu (ErbB2) Breast Test at a cost of 370 AED, making it accessible to a wide range of patients. This cost-effective pricing ensures that individuals have access to this critical diagnostic tool, enabling them to proceed with the appropriate treatment plan based on their HER-2 status.
For more information about the Immunohistochemistry HER-2/neu (ErbB2) Breast Test and to schedule an appointment, please visit DNA Labs UAE.
In conclusion, the Immunohistochemistry HER-2/neu (ErbB2) Breast Test is a pivotal diagnostic tool in the management of breast cancer. It provides essential information on the HER-2 status of the tumor, guiding treatment decisions and prognostic evaluations. DNA Labs UAE remains committed to offering this test, along with a comprehensive suite of diagnostic services, to support patients and healthcare providers in the fight against breast cancer.
